Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. 

Biotechnology

Atomwise

Gavin Hirst

Wenhu Huang

Matthew Merkley

Mallorie Lynch

Ed Kawashiri

Robert Mittendorff

Izhar Wallach

Denzil Bernard

Yan Zhao

Nicole Dishotsky

The Leadership Team at Atomwise consists of key executives who drive the company's strategic vision and operational excellence in AI-driven drug discovery. This team collaborates closely to foster innovation, establish partnerships with industry leaders and academic institutions, and ensure the successful implementation of cutting-edge technologies that significantly accelerate the drug development process. Their collective expertise in science and technology empowers Atomwise to address complex challenges in the pharmaceutical and agrochemical sectors.

Leadership Team

Drug Discovery and Medicinal Chemistry

Directors Team

Leadership Team

About

Team members

Other teams at Atomwise

Drug Discovery and Medicinal Chemistry

Directors Team